Large-scale Mendelian randomization identifies novel pathways as therapeutic targets for heart failure with reduced ejection fraction and with preserved ejection fraction
Danielle Rasooly(Brigham and Women's Hospital), Juan P. Casas(Novartis (Switzerland)), Maik Pietzner(University of Freiburg), Patricia B. Munroe(Queen Mary University of London), Nicole Kosik(VA Boston Healthcare System), John C. Whittaker(University of Cambridge), Eric Farber‐Eger(Vanderbilt University), Claudia Giambartolomei(University College London), Alexandre C. Pereira(University of Washington), Andrew R. Leach(LifeArc), Gina M. Peloso(Boston University), Yan V. Sun(Utah State University), Brian R. Ferolito(VA Boston Healthcare System), Kelly Cho(VA Boston Healthcare System), Jacob Joseph(Lourdes Hospital), Gian Gaetano Tartaglia(Institució Catalana de Recerca i Estudis Avançats), Gabriele Proietti(Italian Institute of Technology), Claudia Langenberg(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Quinn S. Wells(Vanderbilt University), Nay Aung(Queen Mary University of London), Daniel J Golden(Brigham and Women's Hospital), Lawrence S. Phillips(Emory University), Steffen E. Petersen(Queen Mary University of London), Andréa R. V. R. Horimoto(Laboratory of Molecular Genetics), Giorgio Bini(Italian Institute of Technology), Peter W.F. Wilson(VA Tennessee Valley Healthcare System), John Michael Gaziano(Brigham and Women's Hospital), Hesam Dashti(Broad Institute)
Cited by 0
Related Papers
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k
Prediction of Coronary Heart Disease Using Risk Factor Categories
|Circulation|1998|9.6k
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
|Journal of Molecular Biology|1997|6.7k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k